These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11523316)

  • 21. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
    Seino M; Abe K; Sakurai Y; Irokawa N; Yasujima M; Chiba S; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1977 Feb; 121(2):111-9. PubMed ID: 847738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
    Brown NJ; Kumar S; Painter CA; Vaughan DE
    Hypertension; 2002 Dec; 40(6):859-65. PubMed ID: 12468570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
    Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
    J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction.
    Demirkiran A; Everaars H; Elitok A; van de Ven PM; Smulders YM; Dreijerink KM; Tanakol R; Ozcan M
    J Clin Hypertens (Greenwich); 2019 Jul; 21(7):932-941. PubMed ID: 31187936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
    Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
    Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.
    Gismondi RA; Bedirian R; Pozzobon CR; Ladeira MC; Oigman W; Neves MF
    Arq Bras Cardiol; 2015 Dec; 105(6):597-605. PubMed ID: 26465872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T
    Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
    Schiffrin EL; Park JB; Intengan HD; Touyz RM
    Circulation; 2000 Apr; 101(14):1653-9. PubMed ID: 10758046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
    Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
    J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment with enalapril or losartan does not show antiproliferative effects in peripheral blood mononuclear cells.
    Petrov VV; Fagard RH; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):149-52. PubMed ID: 11523315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.
    Ichikawa S; Takayama Y
    Hypertens Res; 2001 Nov; 24(6):641-6. PubMed ID: 11768722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein.
    Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
    Fundam Clin Pharmacol; 2014 Jun; 28(3):237-48. PubMed ID: 23488690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.